NARAMIG

Medicinal product

(Invented) name

NARAMIG

Active substance (s)

Naratriptanas

Strength

2,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC02, Naratriptan

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

1998-06-02

Date of renewal

2009-04-01

Documents

1508 Pakuotės lapelis 2022 06 30.docx

1508 NARAMIG II PL 2022 06 30.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Naratriptanas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
8496	3095	1003095	dvisluoksnė juostelė	N2		Receptinis	LT/1/98/1508/001	Tiekiama	2025-04-29	-	No	-	-	Download

Stadijos

Data	Stadija
2009-04-01	Perregistruotas
1998-06-02	Registruotas